[go: up one dir, main page]

NO874857D0 - Fremgangsmaate til fremstilling av rebeccamycin-analoger. - Google Patents

Fremgangsmaate til fremstilling av rebeccamycin-analoger.

Info

Publication number
NO874857D0
NO874857D0 NO874857A NO874857A NO874857D0 NO 874857 D0 NO874857 D0 NO 874857D0 NO 874857 A NO874857 A NO 874857A NO 874857 A NO874857 A NO 874857A NO 874857 D0 NO874857 D0 NO 874857D0
Authority
NO
Norway
Prior art keywords
alkyl
rebeccamycin
alkoxycarbonyl
carboxyl
mono
Prior art date
Application number
NO874857A
Other languages
English (en)
Other versions
NO167741B (no
NO874857L (no
NO167741C (no
Inventor
Takushi Kaneko
Hanry S Wong
Jacob J Utzig
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO874857D0 publication Critical patent/NO874857D0/no
Publication of NO874857L publication Critical patent/NO874857L/no
Publication of NO167741B publication Critical patent/NO167741B/no
Publication of NO167741C publication Critical patent/NO167741C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO874857A 1986-11-21 1987-11-20 Analogifremgangsmaate for fremstilling av terapeutiske rebeccamycinanaloger. NO167741C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (4)

Publication Number Publication Date
NO874857D0 true NO874857D0 (no) 1987-11-20
NO874857L NO874857L (no) 1988-05-24
NO167741B NO167741B (no) 1991-08-26
NO167741C NO167741C (no) 1991-12-04

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874857A NO167741C (no) 1986-11-21 1987-11-20 Analogifremgangsmaate for fremstilling av terapeutiske rebeccamycinanaloger.

Country Status (28)

Country Link
US (1) US4785085A (no)
EP (1) EP0269025B1 (no)
JP (1) JPS63198695A (no)
KR (1) KR910000897B1 (no)
CN (1) CN1019806B (no)
AT (1) ATE84539T1 (no)
AU (1) AU614068B2 (no)
CA (1) CA1287349C (no)
CS (1) CS265248B2 (no)
CY (1) CY1701A (no)
DE (1) DE3783577T2 (no)
DK (1) DK165986C (no)
EG (1) EG18409A (no)
ES (1) ES2053510T3 (no)
FI (1) FI86189C (no)
GR (1) GR3006776T3 (no)
HK (1) HK49093A (no)
HU (1) HU201773B (no)
IE (1) IE60595B1 (no)
IL (1) IL84515A (no)
MX (1) MX9202849A (no)
MY (1) MY102722A (no)
NO (1) NO167741C (no)
NZ (1) NZ222544A (no)
PT (1) PT86188B (no)
SG (1) SG25193G (no)
YU (1) YU46087B (no)
ZA (1) ZA878714B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
CA2037596C (en) * 1990-03-06 1995-07-18 Kin Sing Lam Rebeccamycin analog by bromide precursor feeding
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
DE69127691T2 (de) * 1990-05-11 1998-01-15 Banyu Pharmaceutical Co., Ltd., Tokio/Tokyo Be-13793c-derivat mit antitumorwirkung
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
JPH07238044A (ja) * 1993-12-07 1995-09-12 Eli Lilly & Co ビスインドリルマレイミドの改良合成法
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
CA2137203C (en) * 1993-12-07 2006-11-28 William Francis Heath Jr. Protein kinase c inhibitors
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
CA2179650C (en) * 1993-12-23 2007-10-30 William Francis Heath, Jr. Bisindolemaleimides and their use as protein kinase c inhibitors
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (fr) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
USRE37206E1 (en) * 1994-06-13 2001-06-05 Banyu Pharmaceutical Co, Ltd Gene encoding glycosyltransferase and its uses
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
US5919946A (en) * 1996-03-20 1999-07-06 Eli Lilly And Company Synthesis of indolylmaleimides
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
KR20030085035A (ko) 2001-03-22 2003-11-01 브리스톨-마이어스스퀴브컴파니 토포아이소머라아제 ｉ 선택성 세포독성인돌로피롤로카바졸 당 유도체
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
WO2005026185A1 (ja) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. 抗腫瘍性新規インドロピロロカルバゾール誘導体
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Also Published As

Publication number Publication date
FI875091A (fi) 1988-05-22
NO167741B (no) 1991-08-26
CY1701A (en) 1994-01-14
DK165986B (da) 1993-02-22
JPS63198695A (ja) 1988-08-17
FI86189C (fi) 1992-07-27
PT86188A (en) 1987-12-01
ES2053510T3 (es) 1994-08-01
FI86189B (fi) 1992-04-15
DE3783577T2 (de) 1993-05-19
EP0269025A2 (en) 1988-06-01
IL84515A (en) 1991-11-21
NO874857L (no) 1988-05-24
FI875091A0 (fi) 1987-11-18
JPH05400B2 (no) 1993-01-05
PT86188B (pt) 1990-11-07
DE3783577D1 (de) 1993-02-25
DK165986C (da) 1993-07-19
DK612987A (da) 1988-05-22
KR910000897B1 (ko) 1991-02-12
CN1019806B (zh) 1992-12-30
AU8114887A (en) 1988-05-26
ZA878714B (no) 1988-05-20
YU208687A (en) 1988-10-31
MX9202849A (es) 1992-06-30
EP0269025A3 (en) 1990-08-29
GR3006776T3 (no) 1993-06-30
NO167741C (no) 1991-12-04
EG18409A (en) 1993-02-28
AU614068B2 (en) 1991-08-22
IE60595B1 (en) 1994-07-27
CS824987A2 (en) 1989-01-12
IL84515A0 (en) 1988-04-29
HUT45543A (en) 1988-07-28
DK612987D0 (da) 1987-11-20
NZ222544A (en) 1990-11-27
CS265248B2 (en) 1989-10-13
HK49093A (en) 1993-05-27
CN87107928A (zh) 1988-08-10
KR880006246A (ko) 1988-07-22
MY102722A (en) 1992-09-30
IE873152L (en) 1988-05-21
YU46087B (sh) 1992-12-21
HU201773B (en) 1990-12-28
EP0269025B1 (en) 1993-01-13
US4785085A (en) 1988-11-15
ATE84539T1 (de) 1993-01-15
CA1287349C (en) 1991-08-06
SG25193G (en) 1993-05-21

Similar Documents

Publication Publication Date Title
NO874857L (no) Fremgangsmaate til fremstilling av rebeccamycin-analoger.
HUT59081A (en) Process for producing aryl- and heteroaryl-ethylene derivatives and pharmaceutical compositions containing them
PT83843B (pt) Processo para a preparacao de promedicamentos de rapamicina
ES8206474A1 (es) Un procedimiento para la obtencion de un derivado acilado sustituido de acido octahidro-1h-indol-2-carboxilico
GB1434323A (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
KR940021532A (ko) 헤테로시클릭 치환된 페닐아세트산 유도체의 페닐글리산아미드
HUT43568A (en) Process for preparing novel 2-pyridiyl-acetic acid derivatives and pharmaceutics comprising the same
FI844184L (fi) Isokinolinderivat och foerfarande foer framstaellning daerav.

Legal Events

Date Code Title Description
MK1K Patent expired